tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MIST is currently covered by 4 analysts with an average price target of $9.11. This is a potential upside of $8.39 (1165.28%) from yesterday's end of day stock price of $0.72.
Milestone Pharmaceuticals's activity chart (see below) currently has 19 price targets and 31 ratings on display. The stock rating distribution of MIST is 92.86% BUY and 7.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 8.57% with an average time for these price targets to be met of 3.6 days.
Highest price target for MIST is $25, Lowest price target is $25, average price target is $12.25.
Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 17-Mar-2025. First documented stock forecast 03-Jun-2019.
Currently out of the existing stock ratings of MIST, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25
$23.1 (1215.79%)
$25
23 days ago
(17-Mar-2025)
0/4 (0%)
$22.59 (937.34%)
Buy
$9
$7.1 (373.68%)
$32
1 years 3 months 13 days ago
(27-Dec-2023)
0/2 (0%)
$7.12 (378.72%)
Buy
$11
$9.1 (478.95%)
$13
1 years 7 months 29 days ago
(11-Aug-2023)
0/6 (0%)
$7.83 (247.00%)
Hold
$4
$2.1 (110.53%)
1 years 9 months 20 days ago
(20-Jun-2023)
0/2 (0%)
$0.56 (16.28%)
Buy
$10
$8.1 (426.32%)
$10
2 years 11 months 7 days ago
(02-May-2022)
3/7 (42.86%)
$3.85 (62.60%)
18
What is MIST (Milestone Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MIST (Milestone Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on MIST (Milestone Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MIST (Milestone Pharmaceuticals)?
Which analyst is the currently most bullish on MIST (Milestone Pharmaceuticals)?
Which analyst is the currently most reserved on MIST (Milestone Pharmaceuticals)?
